INmune Bio stories progress in prostate most cancers trial By Investing.com
BOCA RATON, Fla. - INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology…
INmune Bio shares get sector outperform ranking on AD drug potential By Investing.com
On Thursday, Scotiabank initiated protection on shares of INmune Bio Inc. (NASDAQ:INMB)…
